Opportunity
Federal Register #Docket No. DEA-1700
DEA Notice: Lipomed/LGC Standards Application for Importer Registration of Controlled Substances
Buyer
Drug Enforcement Administration
Posted
April 03, 2026
Respond By
May 04, 2026
Identifier
Docket No. DEA-1700
This notice concerns Lipomed/LGC Standards' application to become a registered importer of controlled substances, as published by the Drug Enforcement Administration (DEA) under the Justice Department. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - Applicant/Vendor: - Lipomed/LGC Standards - Products/Services Requested: - Importer registration for basic classes of controlled substances - No specific drugs, part numbers, or quantities are listed - Notable Requirements: - The notice invites comments or objections from registered bulk manufacturers and applicants regarding the proposed registration - No unique technical or operational requirements are specified - OEMs: - No OEMs are referenced, as this is a registration application, not a product procurement
Description
Lipomed/LGC Standards has applied to be registered as an importer of basic classes of controlled substances. This notice invites comments or objections to the issuance of the proposed registration, with a deadline of May 4, 2026. Registered bulk manufacturers and applicants may also request a hearing on the application by the same date. The application is managed by the Drug Enforcement Administration under the Justice Department.